Cargando…
Carbon Monoxide Diffusion Capacity as a Severity Marker in Pulmonary Hypertension
Carbon monoxide diffusion capacity (DLCO) is negatively associated with patient survival in idiopathic pulmonary hypertension (PH), but is not included in the risk stratification score proposed by the 2015 European guidelines. Since 2015, several new stratification scores based on a 3- or 4-severity...
Autores principales: | Diamanti, Eleni, Karava, Vasiliki, Yerly, Patrick, Aubert, John David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745155/ https://www.ncbi.nlm.nih.gov/pubmed/35011871 http://dx.doi.org/10.3390/jcm11010132 |
Ejemplares similares
-
Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method
por: Freitas, Carolina S. G., et al.
Publicado: (2017) -
Risk Stratification in Pulmonary Arterial Hypertension, Update and Perspectives
por: Vraka, Argyro, et al.
Publicado: (2023) -
Diffusing Capacity for Carbon Monoxide Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Li, Xin, et al.
Publicado: (2021) -
Diffusion lung capacity of carbon monoxide: A novel marker of airways remodeling in asthmatic children?
por: Piacentini, Giorgio L., et al.
Publicado: (2012) -
Carbon monoxide reverses established pulmonary hypertension
por: Zuckerbraun, Brian S., et al.
Publicado: (2006)